411 related articles for article (PubMed ID: 23834153)
1. Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy.
Shi M; Cui J; Xie K
Curr Drug Targets; 2013 Sep; 14(10):1192-202. PubMed ID: 23834153
[TBL] [Abstract][Full Text] [Related]
2. Targeting miRNAs for pancreatic cancer therapy.
Shi M; Xie D; Gaod Y; Xie K
Curr Pharm Des; 2014; 20(33):5279-86. PubMed ID: 24479803
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells.
Duan N; Hu X; Yang X; Cheng H; Zhang W
Int J Clin Exp Pathol; 2015; 8(9):10250-60. PubMed ID: 26617733
[TBL] [Abstract][Full Text] [Related]
4. Targeting FOXM1 in cancer.
Halasi M; Gartel AL
Biochem Pharmacol; 2013 Mar; 85(5):644-652. PubMed ID: 23103567
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis.
Huang C; Du J; Xie K
Biochim Biophys Acta; 2014 Apr; 1845(2):104-16. PubMed ID: 24418574
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
7. FOXM1: From cancer initiation to progression and treatment.
Koo CY; Muir KW; Lam EW
Biochim Biophys Acta; 2012 Jan; 1819(1):28-37. PubMed ID: 21978825
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
9. The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis.
Li D; Wei P; Peng Z; Huang C; Tang H; Jia Z; Cui J; Le X; Huang S; Xie K
Clin Cancer Res; 2013 Jan; 19(1):62-72. PubMed ID: 23136192
[TBL] [Abstract][Full Text] [Related]
10. miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.
Sun Y; Yu X; Bai Q
Int J Clin Exp Pathol; 2015; 8(10):12775-83. PubMed ID: 26722467
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1.
Yuan F; Wang W
Mol Med Rep; 2015 Sep; 12(3):4647-4651. PubMed ID: 26080894
[TBL] [Abstract][Full Text] [Related]
12. FOX(M1) news--it is cancer.
Halasi M; Gartel AL
Mol Cancer Ther; 2013 Mar; 12(3):245-54. PubMed ID: 23443798
[TBL] [Abstract][Full Text] [Related]
13. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
14. The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment.
Gao Y; Feng B; Han S; Zhang K; Chen J; Li C; Wang R; Chen L
Cell Physiol Biochem; 2016; 38(2):427-48. PubMed ID: 26828359
[TBL] [Abstract][Full Text] [Related]
15. FoxM1: a master regulator of tumor metastasis.
Raychaudhuri P; Park HJ
Cancer Res; 2011 Jul; 71(13):4329-33. PubMed ID: 21712406
[TBL] [Abstract][Full Text] [Related]
16. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
[TBL] [Abstract][Full Text] [Related]
18. Targeting FOXM1 auto-regulation in cancer.
Gartel AL
Cancer Biol Ther; 2015; 16(2):185-6. PubMed ID: 25603426
[No Abstract] [Full Text] [Related]
19. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
20. Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer.
Inoguchi S; Seki N; Chiyomaru T; Ishihara T; Matsushita R; Mataki H; Itesako T; Tatarano S; Yoshino H; Goto Y; Nishikawa R; Nakagawa M; Enokida H
FEBS Lett; 2014 Aug; 588(17):3170-9. PubMed ID: 24999187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
